Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 19696123)

1.

Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.

Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group.

Chest. 2009 Nov;136(5):1237-48. doi: 10.1378/chest.09-0087. Epub 2009 Aug 20.

PMID:
19696123
2.

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M.

Crit Care Med. 2006 Jun;34(6):1589-96.

PMID:
16625125
3.

Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA.

Chest. 2003 May;123(5):1615-24.

PMID:
12740282
4.

Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy.

Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group.

Intensive Care Med. 2009 May;35(5):871-81. doi: 10.1007/s00134-008-1367-2. Epub 2008 Dec 9.

PMID:
19066848
5.
6.

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D.

Am J Med. 2003 Nov;115(7):529-35.

PMID:
14599631
7.

Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia.

Cheong HS, Kang CI, Wi YM, Ko KS, Chung DR, Lee NY, Song JH, Peck KR.

Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1219-25. doi: 10.1007/s10096-008-0568-5. Epub 2008 Jun 25.

PMID:
18575908
8.

Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.

Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH.

Surg Infect (Larchmt). 2007 Apr;8(2):189-200.

PMID:
17437364
9.

The effect of time to antifungal therapy on mortality in Candidemia associated septic shock.

Patel GP, Simon D, Scheetz M, Crank CW, Lodise T, Patel N.

Am J Ther. 2009 Nov-Dec;16(6):508-11. doi: 10.1097/MJT.0b013e3181a1afb7.

PMID:
19531934
10.

Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment.

Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH.

Crit Care Med. 2006 Aug;34(8):2069-74.

PMID:
16763516
11.

Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis.

Arabi YM, Dara SI, Memish Z, Al Abdulkareem A, Tamim HM, Al-Shirawi N, Parrillo JE, Dodek P, Lapinsky S, Feinstein D, Wood G, Dial S, Zanotti S, Kumar A; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group.

Hepatology. 2012 Dec;56(6):2305-15. doi: 10.1002/hep.25931.

12.

Early intravenous unfractionated heparin and mortality in septic shock.

Zarychanski R, Doucette S, Fergusson D, Roberts D, Houston DS, Sharma S, Gulati H, Kumar A.

Crit Care Med. 2008 Nov;36(11):2973-9. doi: 10.1097/CCM.0b013e31818b8c6b.

PMID:
18824906
13.
14.

Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.

Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M.

Crit Care Med. 2014 Nov;42(11):2342-9. doi: 10.1097/CCM.0000000000000516.

PMID:
25072764
15.

The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit.

Zaragoza R, Artero A, Camarena JJ, Sancho S, González R, Nogueira JM.

Clin Microbiol Infect. 2003 May;9(5):412-8.

16.

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C.

Crit Care Med. 2003 Dec;31(12):2742-51.

PMID:
14668610
17.

Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.

Oliveira CF, Nogueira de Sá FR, Oliveira DS, Gottschald AF, Moura JD, Shibata AR, Troster EJ, Vaz FA, Carcillo JA.

Pediatr Emerg Care. 2008 Dec;24(12):810-5. doi: 10.1097/PEC.0b013e31818e9f3a.

PMID:
19050666
18.

Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.

Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J.

Crit Care Med. 2007 Aug;35(8):1888-95.

PMID:
17581492
19.

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.

Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA; IL-1RA Sepsis Syndrome Study Group.

Crit Care Med. 1994 Jan;22(1):12-21.

PMID:
8124953
20.

Before-after study of a standardized hospital order set for the management of septic shock.

Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH.

Crit Care Med. 2006 Nov;34(11):2707-13.

PMID:
16943733
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk